![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Weisberg E.
Publisher: Adis International
ISSN: 0312-5963
Source: Clinical Pharmacokinetics, Vol.36, Iss.5, 1999-05, pp. : 309-313
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Is There an Increased Risk of Stroke Associated with Oral Contraceptives?
Drug Safety, Vol. 20, Iss. 6, 1999-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Optimal treatment for PMDD: SSRI or oral contraceptive?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 598, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Antibacterials for the treatment of CHD?
Inpharma, Vol. 1, Iss. 1386, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Antibacterials: to prescribe or not to prescribe?
Inpharma, Vol. 1, Iss. 1222, 2000-01 ,pp. :